SCHEMBL1728527

SCHEMBL1728527

CN(C)CCOc1ccc(-n2ccn(-c3ccc(Oc4ncccn4)cc3)c2=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 4/20 0.51
CYP1A2 P05177 3/20 0.50
CYP2D6 P10635 3/20 0.50
CYP2C9 P11712 3/20 0.50
CYP2C19 P33261 3/20 0.50
LTA4H P09960 2/20 0.49
MAPK14 Q16539 1/20 0.44
CYP3A4 P08684 2/20 0.43
FGFR1 P11362 1/20 0.43
SRC P12931 1/20 0.43
KCNH2 Q12809 3/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
ADORA2B P29275 1/20 0.41
ADORA1 P30542 1/20 0.41
CHRNB2 P17787 1/20 0.41
CHRNA4 P43681 1/20 0.41
HRH3 Q9Y5N1 1/20 0.40
TNK2 Q07912 1/20 0.40
KEAP1 Q14145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1728669 0.86 LTA4H (0.68) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1727505 0.86 MCHR1 (0.46) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1728773 0.84 CHRNB2 (0.59) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1729490 0.84 MAPK14 (0.56) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1727319 0.82 LTA4H (0.51) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL1728528 0.82 LTA4H (0.52) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6080985 0.82 MCHR1 (0.54) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6081903 0.82 MCHR1 (0.54) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6081522 0.82 ALDH1A1 (0.55) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL6082151 0.81 MCHR1 (0.60) MCHR1CYP1A2CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551810-B1 DIARYL-SUBSTITUTED CYCLIC UREA DERIVATIVES HAVING AN MCH-MODULATORY EFFECT SANOFI AVENTIS DEUTSCHLAND (DE) 2011-11-30 EP disclosed
US-7141561-B2 Substituted diaryl heterocycles, process for their preparation and their use as medicaments SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-11-28 US disclosed